These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35896841)

  • 1. Do objective and subjective measures of cognitive impairment predict occupational status in patients with work-related stress? A clinical follow-up study.
    Worm MS; Miskowiak KW; Purdon SE; Flachs EM; Thomsen JF; Eller NH; Jensen JH
    Int Arch Occup Environ Health; 2023 Jan; 96(1):121-130. PubMed ID: 35896841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools.
    Jensen JH; Miskowiak KW; Purdon SE; Thomsen JF; Eller NH
    Scand J Work Environ Health; 2022 Jan; 48(1):71-80. PubMed ID: 34580738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools.
    Jensen JH; Støttrup MM; Nayberg E; Knorr U; Ullum H; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2015 Nov; 187():10-9. PubMed ID: 26301477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults.
    Papaliagkas V; Papantoniou G; Tsolaki M; Moraitou D
    Hell J Nucl Med; 2017; 20 Suppl():58-70. PubMed ID: 29324915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression.
    Tourjman SV; Juster RP; Purdon S; Stip E; Kouassi E; Potvin S
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):49-56. PubMed ID: 29553848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools.
    Ott CV; Bjertrup AJ; Jensen JH; Ullum H; Sjælland R; Purdon SE; Vieta E; Kessing LV; Miskowiak KW
    J Affect Disord; 2016 Jan; 190():607-615. PubMed ID: 26583350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry.
    Tourjman SV; Potvin S; Corbalan F; Djouini A; Purdon SE; Stip E; Juster RP; Kouassi E
    Atten Defic Hyperact Disord; 2019 Jun; 11(2):139-147. PubMed ID: 30225804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA.
    Belvederi Murri M; Folesani F; Costa S; Biancosino B; Colla C; Zerbinati L; Caruso R; Nanni MG; Purdon SE; Grassi L
    Schizophr Res; 2020 Apr; 218():188-194. PubMed ID: 31948897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of neuropsychological tests for employment outcomes in persons with cognitive impairment after moderate to severe traumatic brain injury.
    Sawamura D; Ikoma K; Ogawa K; Sakai S
    Brain Inj; 2018; 32(13-14):1670-1677. PubMed ID: 30351982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder.
    Ott CV; Knorr U; Jespersen A; Obenhausen K; Røen I; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2021 Feb; 281():33-40. PubMed ID: 33285390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of BICAMS and ARCS for assessment of cognition in multiple sclerosis and predictive value of employment status.
    Maltby VE; Lea RA; Ribbons K; Lea MG; Schofield PW; Lechner-Scott J
    Mult Scler Relat Disord; 2020 Jun; 41():102037. PubMed ID: 32200339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The screen for cognitive impairment in psychiatry in patients with borderline personality disorder.
    Folesani F; Belvederi Murri M; Biancosino B; Costa S; Zerbinati L; Caruso R; Nanni MG; Toffanin T; Ferrara M; Purdon SE; Grassi L
    Personal Ment Health; 2022 Nov; 16(4):279-289. PubMed ID: 35146968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The screen for cognitive impairment in psychiatry (SCIP) as a routinely applied screening tool: pathology of acute psychiatric inpatients and cluster analysis.
    Schmid P; Czekaj A; Frick J; Steinert T; Purdon SE; Uhlmann C
    BMC Psychiatry; 2021 Oct; 21(1):494. PubMed ID: 34627191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of clinically relevant correlation between subjective and objective cognitive function in ICU survivors: a prospective 12-month follow-up study.
    Brück E; Larsson JW; Lasselin J; Bottai M; Hirvikoski T; Sundman E; Eberhardson M; Sackey P; Olofsson PS
    Crit Care; 2019 Jul; 23(1):253. PubMed ID: 31300016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
    Rojo E; Pino O; Guilera G; Gómez-Benito J; Purdon SE; Crespo-Facorro B; Cuesta MJ; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Mesa F; Rejas J;
    Schizophr Res; 2010 Feb; 116(2-3):243-51. PubMed ID: 19744832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Internet-Based Cognitive Assessment Tool: System Design and Feasibility Study.
    Hafiz P; Miskowiak KW; Kessing LV; Elleby Jespersen A; Obenhausen K; Gulyas L; Zukowska K; Bardram JE
    JMIR Form Res; 2019 Jul; 3(3):e13898. PubMed ID: 31350840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a "subjective motoric cognitive risk syndrome" screening tool for motoric cognitive risk syndrome-A prospective cohort study.
    Ayers E; Wang C; Verghese J
    Eur J Neurol; 2022 Oct; 29(10):2925-2933. PubMed ID: 35748730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian Validation of the Screen for Cognitive Impairment in Psychiatry.
    Belvederi Murri M; Folesani F; Costa S; Morelli AC; Scillitani V; Guaiana G; Biancosino B; Caruso R; Nanni MG; Zerbinati L; Purdon SE; Grassi L
    Community Ment Health J; 2020 Nov; 56(8):1411-1418. PubMed ID: 32076904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?
    Svendsen AM; Kessing LV; Munkholm K; Vinberg M; Miskowiak KW
    Nord J Psychiatry; 2012 Sep; 66(4):248-53. PubMed ID: 22070515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.